PTH and chronic kidney disease: Serum ALP and intact or bio-intact PTH levels mirror quite well the underlying bone turnover state; combined measurement of these 2 biomarkers can be used to evaluate bone disease in CKD patients and drive the therapeutic and follow-up strategies (280).